RE:RE:Clearly an OVER Reaction
Capitulation. Apparently 20 of the largest shareholders own a bit less than 50% which means some of them have probably bailed, but there is no doubt a ton of HF day trading happening. As I stated previously, lawsuits are pending if results are found to be flawed. If there was any question as to the veracity of the results they should not have been released. The company has set themselves up for major legal problems now. Would have been better to halt the stock pending verification of the results. Allowing trading on inaccurate or bad info is not what is suppose to happen. Perhaps 23 Dec delay was for that purpose. Next 6 - 8 weeks critical. In short term, stock either going back to $3- $4 range (if Trilogy 2 results very favorable and Trilogy 1 results plausibly figured out with good secondaries) or about 20 cents (Trilogy 2 results similar to T1) as company will have to call it a day and buy back shares with their remaining funds. Won't that be fun.